Some recently released research uncovered a couple of disconcerting trends concerning prescription drugs. Lawsuit ads targeting prescription drugs and medical devices have caused at least 61 serious medical events, including six deaths, according to a report from the U.S.
Amazon has quietly received approvals for pharmacy wholesale licenses from at least a dozen state pharmacy boards, the St. Louis Post-Dispatch reported Thursday.
Published reports said Thursday that CVS Health is in negotiations to acquire health insurer Aetna.
including government — can afford to pay for them. But strides toward unraveling the tangle of problems behind this issue won’t be made without determined attempts at substantive discussion between the public and private sectors, according
CVS Health continues to back up its mantra of getting people “on the path to better health” with action. Having dropped tobacco from its stores and refocused its front end on better-for-you products, CVS is taking aim at e-cigarettes.
Not all pharmacy patient reviews are the same, according to digital health specialist RxWiki. The Austin, Texas-based company, known for its Digital Pharmacist software-as-a-service (SaaS) platform, on Thursday said it has launched Patient Verified Reviews.
Though Fred’s name came up in the buzz surrounding the Walgreens-Rite Aid merger talks with the FTC, the Southeastern retailer’s move to buy 865 Rite Aid stores for $950 million in cash from Walgreens Boots Alliance (WBA) still was surprising.
spurred by the rising use of mobile shopping — influenced $14.5
Chain drug industry watchers have kept hearing and reading the scuttlebutt about the closing of the Walgreens-Rite Aid merger deal. But a report late Friday afternoon suggested that approval of the $17.2 billion transaction may be imminent.
Even with all the data and analytics tools available, getting a bead on today’s consumer isn’t easy.
CVS Health returned fire to rising competition (read: Walgreens) in the pharmacy network arena with this week’s announcement of its 90-day-at retail program with OptumRx, Wolfe Research analyst Scott Mushkin said.
and more specifically, pharmacy care. Technology-led PBM RxAdvance last week announced Sculley as its chairman and chief marketing officer. The move expands his role at the company, where he’s a founding investor and had served as vice chairman. “Convincing
CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance.
Walgreens Boots Alliance and Rite Aid recently extended the agreement end date for their merger transaction until late January, with the expectation that the deal will get the Federal Trade Commission’s OK in early 2017.
